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Abstract 
 
CDKL5 deficiency disorder (CDD) is a neurodevelopmental disorder characterized by a           
severe global developmental delay and early-onset seizures. Notably, patients show          
distinctive visual abnormalities often clinically diagnosed as Cortical Visual Impairment.          
However, the involvement of cerebral cortical dysfunctions in the origin of the symptoms             
is poorly understood. CDD mouse models display analogous visual deficits and cortical            
visual responses can be used as a robust biomarker in CDKL5 mutant mice. A deeper               
understanding of the circuits underlying the described visual deficits is essential for            
directing preclinical research and translational approaches. Here we addressed this          
question in two ways: first, we performed an in-depth morphological analysis of the             
visual pathway, from the retina to the primary visual cortex (V1), of CDKL5 null mice.               
We found that CDKL5 lack produced no alteration in the organization of retinal circuits.              
Conversely, CDKL5 mutants showed reduced density and altered morphology of          
spines, and decreased excitatory synapse marker PSD95 in the dorsal Lateral           
Geniculate Nucleus and in V1. An increase in the inhibitory marker VGAT was             
selectively present in V1. Second, using a conditional KO model, we showed that             
selective cortical deletion of CDKL5 from excitatory cells is sufficient to produce            
abnormalities of visual cortical responses, demonstrating that the normal function of           
cortical circuits is dependent on CDKL5. Intriguingly, these deficits were associated with            
morphological alterations of V1 excitatory and inhibitory synaptic contacts. In summary,           
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this work proposes cortical circuit structure and function as a critically important target             
for studying CDD. 
 
  
2 
Introduction 
In humans, mutations in CDKL5 cause a devastating disorder of neurodevelopment           
designated CDKL5 deficiency disorder (CDD). Patients are characterized by a severe           
global developmental delay, early-onset seizures, and a distinctive visual impairment          
(Moseley et al. 2012; Stalpers et al. 2012) often clinically diagnosed as Cortical Visual              
Impairment (CVI). CVI, also designated as cerebral visual impairment, is generally due            
to alterations involving the retrochiasmal visual tracts in the brain with nonexistent or             
minimal ocular morbidity ​(Lehman 2012)​. However, little is known about the neural            
structures involved in CVI in CDD patients. During the last years, CDD mouse models              
have become available ​(Wang et al. 2012; Amendola et al. 2014; Jhang et al. 2017;               
Okuda et al. 2017)​, paving the way to mechanistic and preclinical investigations on             
possible therapies. These studies have produced a plethora of preclinical data,           
however, the efficacy assessment of these potential treatments in a clinical trial critically             
depends on the availability of noninvasive biomarkers with high sensitivity.          
Unfortunately, these tools are still missing. Previous studies demonstrated that visual           
cortical responses assessed by visual evoked potential (VEP) recordings or intrinsic           
optical signal (IOS) imaging (a technique to dynamically image the activity-dependent           
blood oxygenation dependent signal) can be used to monitor the progression of the             
symptoms in a CDD mouse model ​(Mazziotti et al. 2017)​. Sensitivity analysis revealed             
that visual responses were able to correctly classify mice as mutant or wild-type with              
more than 93% accuracy and 92% sensitivity proving the robustness of this technique in              
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phenotype assessment. Defects in sensory processing have also been reported using           
auditory evoked potentials ​(Wang et al. 2012)​. These observations raise the possibility            
that visual alterations could represent a biomarker of high translational potential for            
CDD. To gain a deeper understanding of the circuits underlying visual deficits induced             
by CDKL5 deficiency, we characterized the morphofunctional defects present at          
different levels along the retino-cortical projection in CDKL5 mutant mice. Our data            
show that, although CDKL5 is expressed in the retina, its deletion does not alter any of                
its major neuronal populations. By contrast, neurons in the visual thalamic relay nucleus             
(the dorsal lateral geniculate nucleus dLGN) and in the visual cortex showed reduced             
spine density and PSD95 synaptic staining in CDKL5 germline knockout mice. To            
understand whether the impairment in cortical visual responses present in CDKL5           
mutants originates from alterations occurring at the thalamic level, we used IOS maging             
to record the amplitude of primary visual cortical activation in response to visual             
stimulation in conditional CDKL5 mutant mice with preserved CDKL5 expression in           
subcortical nuclei. We found that the selective deletion of CDKL5 from cortical excitatory             
and some glial cells is sufficient to produce abnormalities of visual cortical responses,             
demonstrating that CDKL5 plays an essential role in establishing or maintaining a            
normal function of cortical circuitry. 
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Results 
CDKL5 null mice show normal retinal morphology 
CDKL5 deletion results in structural and functional abnormalities in the visual cortex            
(Mazziotti et al. 2017; Pizzo et al. 2016)​. In order to assess whether CDKL5 deletion               
also affects upstream structures of the visual system, we first analyzed the retina of              
mice with CDKL5 deletion (CDKL5​-/y​) ​(Amendola et al. 2014)​. We first performed a             
Western Blot analysis on adult male CDKL5​-/y (N=4) and WT (CDKL5​+/y N=4) retinal             
homogenates to demonstrate CDKL5 retinal expression. Our data (Fig.1A) indicate that           
CDKL5 is expressed at the protein level in the retina, in accordance with RNA seq data                
showing CDKL5 in NRL-positive rods ​(J.-W. Kim et al. 2016)​. No signal was observed at               
the expected molecular weight in the retina of CDKL5 null mice confirming the             
specificity of the CDKL5 antibody. This prompted us to assess the effect of the lack of                
CDKL5 on retinal organization. We stained retinal tissue of P28 male CDKL5​-/y (N=3)             
and CDKL5​+/y (N=3) mice with an extensive set of markers for diverse cell types and               
markers of connectivity. Staining for cone photoreceptors (Cone Arrestin positive cells)           
and rod outer segments (Rhodopsin positive cells) in retinal sections (Fig.1B,C)           
revealed that the overall structural organization of photoreceptor cells is identical in the             
two experimental groups. We then proceeded to assess the total number of selected             
cell types (cones, cholinergic amacrine cells, and ganglion cells) using whole mount            
preparations. No statistical difference between CDKL5​-/y and CDKL5​+/y ​mice was present           
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in the number of cone photoreceptors (cone-Arrestin positive cells, Fig.1D-F, two-tailed           
Student's t-test p=0.435), retinal ganglion cells (RGCs) (RNA-binding protein with          
multiple splicing, RBPMS positive cells, Fig.1G-I, two-tailed Student's t-test p=0.098)          
and cholinergic amacrine cells (GAD67, ChAT double positive cells) both in the Inner             
Nuclear Layer (INL) (Fig.S2C-F, two-tailed Student's t-test p=0.782) and in the Ganglion            
Cell Layer (GCL) (Fig.S2C-F, two-tailed Student's t-test p=0.932). To further          
characterize how the structural organization of the retina is influenced by the lack of              
CDKL5, we performed immunohistochemical experiments for specific markers of         
different retinal subpopulations on vertical sections of CDKL5​-/y (N=3) and CDKL5​+/y           
(N=3) retinas. This analysis reveals cellular morphology, layering and connectivity          
allowing an in-depth assessment of possible abnormalities. We investigated the          
following cell types: cholinergic amacrine cells (GAD67, ChAT double positive cells,           
Fig.S2A,B); horizontal and amacrine cells (CalbindinD positive cells) together with type           
2 cone bipolar cells and axonal endings of type 6 cone bipolar cells             
(ZNP1/Synaptotagmin staining, Fig.S1A,B). Rod bipolar cells (Protein Kinase Cα         
(PKCα) positive cells) were analyzed in combination with a marker of synaptic ribbons             
(C-terminal-binding protein 2, (CtBP2/RIBEYE) staining) in the outer and inner plexa of            
the retina (Fig.S1C,D). Finally, we labeled Müller glial cells (glutamine synthetase (GS)            
positive cells) in combination with a gap-junction subunit (Connexin36) abundant in the            
inner plexiform layer of the retina (Fig.S1E,F). We found no qualitative alterations in the              
morphology and distribution of any of these retinal markers. In summary, this series of              
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experiments indicate that the lack of CDKL5 does not alter the morphological            
organization of retinal circuits. 
CDKL5​-/y mice show synaptic alterations in the lateral geniculate         
nucleus and in the primary visual cortex 
CDKL5 is also expressed in the mouse thalamus ​(Rusconi et al. 2008)​. For this reason,               
we next asked whether the lack of CDKL5 could affect the circuits of the dorsal lateral                
geniculate nucleus (dLGN), the next station of the visual information pathway from the             
retina to the primary visual cortex. Since CDKL5 is known to regulate spine formation              
and stability in the cortex and hippocampus ​(Trazzi et al. 2018; Della Sala et al. 2016)​,                
we assessed density and morphology of dendritic spines in Golgi-stained slices (Fig.2A)            
of the dLGN of CDKL5​-/y (N=4) and CDKL5​+/y (N=5) control littermates. CDKL5​-/y mice             
showed a reduction in spine density (Fig.2B, two-tailed Student’s t-test p=0.026). To            
evaluate spine morphology, we classified spines as immature (filopodia, thin-shaped          
and stubby-shaped) or mature (mushroom and cup-shaped) ​(Matsuzaki et al. 2001;           
Trazzi et al. 2016)​. CDKL5 null mice had a greater proportion of immature spines              
(Fig.2C, χ​2 ​test p=0.0027) compared to the controls. Furthermore, the distribution of            
spines in classes was significantly skewed towards a more immature state in mice             
lacking CDKL5 (Fig.2D, χ​2 ​test p=0.0009). To corroborate this result we performed            
immunohistochemistry, staining for PSD95, a postsynaptic marker of excitatory synapse          
maturation ​(Scannevin and Huganir 2000)​. Consistently with Golgi-staining data,         
CDKL5​-/y mice (N=6) showed a strong decrease in the density of PSD95 positive puncta              
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with respect to CDKL5​+/y (N=6, two-tailed Student's t-test p<0.0001, Fig.2E,F).          
Moreover, to assess the impact of the lack of CDKL5 onto inhibitory circuitry, we stained               
for VGAT, a presynaptic marker of inhibitory synapses ​(Chaudhry et al. 1998)​. The             
results showed no significant alterations in VGAT positive puncta suggesting that the            
lack of CDKL5 produces synaptic alterations in the dLGN occurring at the level of              
excitatory connections.  
Previous in-vivo studies ​(Della Sala et al. 2016) showed that CDKL5 KO mice             
demonstrated decreased dendritic spine stability in cortical neurons in the          
somatosensory cortex. We, therefore, asked whether a spine density deficit was present            
also in V1. This possibility was suggested by findings showing downregulation of the             
density of PSD95 positive puncta in this area ​(Pizzo et al. 2016)​. Golgi-staining in V1               
coronal slices of CDKL5 KO mice unveiled a decreased spine density in layer 2/3              
(Fig.3) and layer 5 (Fig.S3) apical dendrites of pyramidal neurons in CDKL5​-/y animals             
(N=4) with respect to CDKL5​+/y controls (Fig.3A, N=5, two-tailed Student's t-test           
p<0.003; FigS3A). Furthermore, analyzing the distribution of spines in morphological          
classes, we found a lower proportion of mature spines (Fig.3B, Fisher’s exact test             
p<0.001; Fig.S3B) and an increased fraction of filopodia-like, thin and stubby spines            
(Fig.3C, χ​2 ​test p<0.001, Fig.S3C). These morphological abnormalities were coupled to           
a reduction in the PSD95​+ puncta in CDKL5​-/y (N=6) versus CDKL5​+/y (Fig.3D,E, N=6,             
two-tailed Student's t-test p<0.001) animals, confirming previous results ​(Pizzo et al.           
2016)​. Interestingly, we also found an increase in the density of VGAT​+ puncta             
(Fig.3F,G, two-tailed Student's t-test p=0.0135). Taken together, these results confirm          
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that the lack of CDKL5 leads to a complex dysregulation of synaptic morphological             
markers. Excitatory spines are consistently reduced in both the dLGN and in the visual              
cortex, while V1 shows an additional specific increase in inhibitory connections. 
Impaired visual responses in mice with deletion of CDKL5 in          
cortical excitatory neurons 
CDKL5 mutant mice present a deficit in the processing of visual stimuli that can be               
assessed with a remarkably high discrimination power by IOS imaging of visually            
evoked responses ​(Mazziotti et al. 2017)​. These abnormal visual responses, however,           
could arise from defects in upstream visual areas with no intrinsic dysfunction present in              
visual cortical circuits. In order to assess the specific contribution of the visual cortex,              
we used a conditional KO mouse model in which the removal of the floxed CDKL5 allele                
in mutant mice (CDKL5​flox/y​) was achieved by crossing these mice with mice expressing             
CRE-recombinase driven by the emx1 promoter (emx1-CRE​+/-​). As a result,          
CDKL5​flox/y​;emx1-CRE​+/- animals (cKO) lack CDKL5 only in cortical excitatory neurons          
and in some glial cells ​(Gorski et al. 2002)​, thus sparing all the subcortical visual areas                
(Fig.S4). The expression of CRE-recombinase driven with the emx1 promoter is known            
to induce recombination as early as at embryonic day (E) 10.5 ​(Gorski et al. 2002)​, a                
time point in which the expression of all the most abundant isoforms of CDKL5 in the                
mouse brain is still very low ​(Hector et al. 2016)​. This ensures that the phenotypic               
effects observable in adult mice are the result of an altered development or maturation,              
closely resembling CDKL5 null mice and patients. 
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To explore the role of cortical CDKL5 in the pathogenesis of visual deficits in CDKL5               
mutants, we first asked whether the morphological alterations previously identified in           
germline CDKL5 null mice were present in cKO mice in which CDKL5 is normally              
present in subcortical visual nuclei. Since the retina is unaffected in CDKL5 germline             
mutants, we began evaluating the presence of such alterations in the visual pathway of              
cKO mice from the dLGN. Spine density and morphology (N=4 per group), PSD95​+             
puncta (N=3 per group), and VGAT​+ puncta (N=4 per group) were analyzed in cKO and               
WT littermates. The results showed that spine density in the dLGN of ccKO mice was               
not different from WT control mice (Fig.4A, two-tailed student’s t-test p=0.528).           
Moreover, both the proportion of mature and immature spines (Fig.4B, χ​2 ​test p=0.061)             
and their morphology (Fig.4C, χ​2 ​test p=0.163) were unaltered. Finally, the density of             
PSD95​+ ​and VGAT​+ puncta did not differ between WT and cKO mice (Fig.4D-G,             
two-tailed Student's t-test P=0.533 for PSD95; P=0.812 for VGAT). Thus, as expected            
from the pattern of expression of Cre recombinase, the cKO model preserves the             
integrity of the subcortical retino-cortical pathway, allowing to study of the role of cortical              
CDKL5 in the genesis of visual alterations. 
We then asked whether cortical CDKL5 plays a necessary role in the normal physiology              
of cortical visual processing. To this purpose, we performed IOS imaging, recording            
visually evoked responses in male cKO animals (N=8) and, as a control, in parental              
mouse lines expressing CRE (N=5, emx1-CRE​+/-​) or carrying a CDKL5 floxed allele            
(N=9, CDKL5​flox/y​, Fig.5C,D). IOS response amplitude to visual stimulation was          
significantly different between groups (Fig.5A one way ANOVA p=0.004). cKO animals           
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showed a decreased response amplitude with respect to both CRE expressing mice            
(post-hoc Holm-Sidak’s multiple comparisons test, emx1-CRE​+/- ​vs cKO, p=0.0342) and          
CDKL5 floxed mice (post-hoc Holm-Sidak’s multiple comparisons test, CDKL5​flox/y ​vs          
cKO, p=0.004). Such a reduced response is also evident in the average time-course of              
the cortical reflectance for each group (Fig.4C). In order to further characterize the             
precise impact of cortical CDKL5 onto the visual deficit, we also recorded IOS             
responses from germline mutant mice. As expected from previously published data           
(Mazziotti et al. 2017) this cohort recapitulated the impairment in the amplitude of visual              
responses (Fig5B, two-tailed Student's t-test p<0.001). Interestingly, by quantitatively         
measuring the magnitude of the impairment using Cohen’s d as an effect size estimator              
(Cohen 2013)​, we noticed that the effect produced by the germline deletion of CDKL5              
was bigger (Cohen’s d= 2.78) that the one produced by conditional deletion from             
excitatory cortical cells (Cohen’s d= 1.73), although the effect size can be regarded as              
very large for both CDKL5 null mice and cKO ​(Sawilowsky 2009)​. Thus, the effect size               
analysis suggest a major role for the cortex in generating the visual phenotype although              
it cannot be excluded an enhancement of the deficit by defects in other brain areas or                
cell types.  
cKO animals lack CDKL5 from only excitatory cortical neurons and some glial cells. To              
characterize the structural abnormalities underlying such functional deficit, we         
performed a series of anatomical analysis in the V1 of cKO animals. Surprisingly,             
dendritic protrusion density in Golgi-stained dendrites of layer 2/3 (Fig.6) and layer 5             
(Fig.S3) cortical cells was increased in cKO animals compared to controls (Fig.6A,            
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two-tailed Student's t-test p=0.0014, Fig.S3D). This increase, however, was         
accompanied by a marked shift in dendritic spine morphology towards a more immature             
state (Fig6B, χ​2 ​test p<0.001, Fig6C, χ​2 ​test p<0.001, Fig.S3E,F). In accordance with the              
increase in spine density, also the density of PDS95​+ puncta was increased (Fig.6D,F,             
two-tailed Student's t-test P=0.0085) in the cKO animals. Intriguingly, despite the fact            
that CDKL5 deletion happened only in excitatory cells, we also found an increase in the               
density of VGAT​+ puncta (Fig.6E,G, two-tailed Student's t-test P<0.001) suggesting that           
a complex interaction between excitatory and inhibitory cells, possibly involving non           
cell-autonomous effects, might be induced by CDKL5 mutations. 
 
Discussion 
Visually evoked responses are widely used for assessment of visual function in            
humans. They can be measured rapidly and noninvasively from the scalp by extracting             
and averaging evoked signals from electroencephalographic activity recorded during a          
passive fixation task. In particular, the VEP waveform is fully mature by the end of the                
first year of life, allowing for longitudinal studies throughout development in children            
(Lenassi et al. 2008)​. These features make the VEP, or functional imaging, an ideal              
translational tool for functional assessment in children with neurodevelopmental         
disorders. Indeed, previous studies showed abnormal visual responses in animal          
models of CDD ​(Mazziotti et al. 2017) and other closely related disorders ​(Durand et al.               
2012; Boggio et al. 2016)​. Importantly, a standardized analysis of visual responses was             
12 
found to be useful to reveal stage-specific alterations in Rett syndrome patients            
(LeBlanc et al. 2015)​. However, a dissection of the abnormalities in the visual circuitry              
responsible for the origin of VEP alterations remains elusive. Indeed, damage anywhere            
along the visual path may affect the signal in the cortex. Our study provides evidence               
supporting a cortical origin of the visual response deficit occurring in a mouse model of               
CDD. Indeed, visual cortical neuronal morphology in the visual cortex was strongly            
affected by CDKL5 mutation, and deletion of CDKL5 from excitatory cells of the visual              
cortex was sufficient to elicit a significant impairment of visual responses. Moreover,            
although CDKL5 was found to be present in the retina, no differences in retinal laminar               
organization, morphology and fine structural features were observed. This analysis was           
performed using a battery of specific antibodies labeling cellular components of either            
the retinal vertical pathway of information flow (specifically, photoreceptors, rod, and           
cone bipolar cells and ganglion cells) or horizontal modulatory elements (horizontal and            
amacrine cells). In particular, no abnormalities were evident in the photoreceptors or            
ganglion cell layers, which undergo major degeneration in a number of diseases, such             
as, respectively, retinitis pigmentosa and glaucoma ​(Cuenca et al. 2014; Soto and            
Kerschensteiner 2015)​. Furthermore, no signs of glial hyperreactivity (a generalized          
indicator of tissue damage) were found, and inner retinal layers, whose structure and             
distribution of synaptic proteins remodel in inherited photoreceptor degeneration         
(Vidal-Sanz et al. 2012; Strettoi 2015) and diabetic retinopathy ​(Barber and Baccouche            
2017)​, were also intact. Cholinergic amacrines, a sensitive marker of the retinal            
patterning and laminar positioning were also normal ​(Reese and Keeley 2016)​. Hence,            
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although subtle molecular differences cannot be totally ruled out, we can conclude that             
retinal morphology in CDKL5 null mice is indistinguishable from that of age-matched,            
WT animals. 
Our analysis of visual pathway integrity in CDKL5 null mice continued with the             
study of the LGN, a thalamic nucleus relaying visual information from the retina to the               
visual cortex. CDKL5 is known to be expressed in the thalamus and we found that LGN                
neurons from CDKL5 null mice displayed reduced spine density and PSD95 synaptic            
staining. CDKL5 is highly concentrated in dendritic spines ​(Zhu et al. 2013; Ricciardi et              
al. 2012) where it interacts with essential protein components of mature synapses like             
PSD95 and NGL-1, respectively a major scaffold protein in the postsynaptic density and             
a cell adhesion molecule crucial in synapse formation and maturation ​(E. Kim and             
Sheng 2009; Ricciardi et al. 2012; Zhu et al. 2013)​. Its absence determines a reduction               
in dendritic complexity, spine density, and stability both in vitro and in vivo ​(Trazzi et al.                
2018; Della Sala et al. 2016; Fuchs et al. 2018; Okuda et al. 2018)​. These mechanisms                
have not been addressed specifically in thalamic cells, however, they could be involved             
in the deficits observed in LGN neurons. 
At the functional level, thalamic deficits induced by CDKL5 absence seems to be             
dispensable for visual response deficits, indeed conditional deletion of CDKL5 from           
cortical excitatory cells is sufficient to reduce visual responses even if LGN dendritic             
spines and synaptic PSD95 staining are normal. The use of the emx-1 promoter to drive               
Cre recombinase expression and CDKL5 deletion also preserves CDKL5 expression in           
inhibitory neurons. CDKL5 deletion from inhibitory cells has been previously shown to            
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produce a partial phenotype ​(Amendola et al. 2014; Schroeder et al. 2018)​. Our data              
suggest that CDKL5 deficiency in these cells seems dispensable for the reduction of             
visual responses, although they do not exclude an indirect involvement of inhibitory cells             
in the visual impairment of CDKL5 cKO. Indeed, our morphological analysis showed            
dramatic rearrangements occurring both in excitatory and inhibitory synaptic contacts in           
the cKO mouse. This non-cell autonomous phenotype is reminiscent of the one            
observed in the hippocampus of CDKL5 mutants with deletion restricted to excitatory            
neurons ​(Tang et al. 2017) where an increase in the frequency of miniature inhibitory              
synaptic currents was observed. These indirect effects of CDKL5 mutation could be            
relevant for the understanding of the circuit deficits present in CDD patients that are              
often a mosaic of normal and mutant cells. In summary, our study demonstrates a key               
role for CDKL5 in the physiology of postretinal visual pathways. Previous work showed             
that visual impairment is present in CDD patients and represents a biomarker of high              
accuracy and sensitivity to classify CDD mice ​(Mazziotti et al. 2017)​. Our data provide a               
neurobiological background for the use of visual responses for assessment in CDD. 
Materials and Methods 
Mice housing and handling 
Animals were maintained in rooms at 22°C with a standard 12-h light-dark cycle. During              
the light phase, a constant illumination below 40 lux (measured at the cage) from              
fluorescent lamps was maintained. Food (standard diet, 4RF25 GLP Certificate,          
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Mucedola srl) and water were available ad libitum and changed weekly. Open-top cages             
(36.5 x 20.7 x 14 cm; 26.7 x 20.7 x 14 cm for up to 5 adult mice or 42,5 x 26.6 x 15.5 cm                         
for up to 8 adult mice) with wooden dust-free bedding were used. All the experiments               
were carried out in accordance with the directives the European Community Council            
(2011/63/EU) and approved by the Italian Ministry of Health. All necessary efforts were             
made to minimize both stress and the number of animals used.  
The CDKL5 mutant mouse strain used in this work derives from the C57BL/6N             
background, has been developed in ​(Amendola et al. 2014) and has been backcrossed             
in C57BL/6J for five generations. Colony founders were selected for the absence of the              
rd8 retinal degeneration allele spontaneously present in C57BL/6N mice ​(Mattapallil et           
al. 2012)​. Male WT mice were bred with female heterozygous to obtain mutant and WT               
littermates. To generate conditional knock-out mice lacking CDKL5 only from pallial           
structures, sparing most of the subcortical regions, we crossed homozygous mice           
bearing a floxed version of CDKL5, described in ​(Amendola et al. 2014) with mice              
expressing CRE recombinase under the control of emx1 promoter (The Jackson           
Laboratory; B6.129S2-Emx1​tm1(cre)Krj​/J, Stock No: 005628) ​(Gorski et al. 2002)​.         
Genotyping (P10-12) was performed on ear tissue. Weaning was performed at P21-23.            
Data analysis was performed by experimenters blind to the genotype. 
Western Blot 
Adult (>P120) CDKL5​+/y (N=4) and CDKL5​-/y (N=4) male mice were sacrificed by            
decapitation, and retinas were rapidly removed from eyes. The retinal extracts were            
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homogenized in a Ripa Buffer and protein concentration was determined with the            
Bio-Rad protein assay kit. Total lysates were boiled in SDS sample buffer, separated             
by SDS–PAGE and blotted to nitrocellulose membrane (Bio-Rad). Filters were blocked           
in Blocking Odyssey Buffer (Licor) and incubated with primary antibody for 16 h at              
4°C following the instruction of Odyssey System (Licor). The following primary           
antibodies were used: anti-CDKL5 (S957D) 1:750 (Division of Signal Transduction          
Therapy at the University of Dundee) and beta-tubulin (anti-mouse 1:3000, Sigma).           
After washing three times with PBS and Blocking Odyssey Buffer (Licor) 1:1, filters             
were incubated with secondary antibodies IRDye® 680LT/800CW Goat (Polyclonal)         
anti-sheep or anti-mouse IgG, diluted 1:20000 (Licor) for 2h at room temperature.            
Detection was performed by Odyssey System CLX. 
Immunohistochemistry on retinal tissue 
Tissue preparation and histology 
Adult (>p120) male mice were anesthetized with intraperitoneal injections of Avertin           
(3-bromo-ethanol in 1% tert-amyl alcohol) (0.1 ml/5 g body weight). Eyes, which were             
previously labeled on the dorsal pole with a surgical skin marker (Secureline Surgical             
Skin Marker, Aspen Surgical, USA) were quickly enucleated and immersed in 0.1 M             
phosphate buffer (PB), followed by removal of the anterior segments (cornea, iris, lens).             
Mice were sacrificed by quick cervical dislocation. Eyecups were immediately fixed in            
4% paraformaldehyde (PFA) in 0.1 M PB, pH 7.4, for 30/60 minutes at room              
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temperature. Repeated (5x5 minutes) washes were performed in 0.1 M PB, followed by             
incubation in 30% w/w sucrose dissolved in 0.1 M PB overnight at 4 °C and infiltration in                 
Tissue-Tek O.C.T. compound (4583, Sakura Olympus, Italy). Sample freezing in plastic           
cryo-molds was achieved using isopentane cooled down with dry ice; samples were            
stored at −20 °C until further use. Frozen, vertical sections were cut at a cryostat at 12                 
µm thickness and collected on Superfrost slides for immunohistochemistry (IHC). For           
whole-mount preparations, defrosted eyecups were extensively washed in phosphate         
buffered saline (PBS), the retina was gently detached from the sclera and flattened by              
making four radial cuts toward the optic nerve head maintaining a reference on the              
dorsal pole. For IHC, both retinal whole mounts and sections were incubated in:             
blocking solution (0.03% Triton-X 100 + 5% serum from the species in which the              
secondary antibody was generated in 0.01 M PBS), for 2 hours at room temperature if               
sections and overnight at 4 °C if whole mounts; primary antibody (Ab) solution (diluted              
in PBS + 0.01% Triton-X 100 + 1% serum), overnight at 4 °C for sections and 3 days at                   
4 °C for whole mounts. The antigen-antibody complex was revealed by incubation in             
fluorescent secondary Ab solution – diluted as the primary Ab – for 2 hrs at room                
temperature for sections and 2 days at 4 °C for retinal whole mounts. 
Antibodies 
Mouse monoclonal primary antibodies used on retinal specimens were: C-Terminal          
Binding Protein-2 (CtBP2/RIBEYE; 612044; BD Biosciences; diluted 1:800);        
Postsynaptic Density-95 (PSD95; ab13552; Abcam Ltd., Cambridge, UK; diluted 1:500);          
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ZNP-1/Synaptotagmin-II (ZNP-1; kind gift from Prof. Erica Fletcher, developed at the           
Zebrafish International Research Centre (ZIRC), University of Oregon, US; diluted          
1:1000); Glutamic Acid Decarboxylase-67 (GAD67; MAB5406; Merck-Millipore, Italy;        
diluted 1:500). 
Rabbit polyclonal primary antibodies were: Cone Arrestin (AB15282, Merck-Millipore,         
Italy; diluted 1:5000); Calbindin D (CB38a, Swant Ltd., Switzerland, diluted 1:500);           
Protein Kinase Cα (PKCα; P4334, Sigma-Aldrich, Italy; diluted 1:800); RBPMS          
(1830-RBPMS; PhosphoSolutions, Colorado; diluted 1:500).  
A goat polyclonal Choline Acetyltransferase (ChAT, AB144P, Merck-Millipore, Italy;         
1:500) was also used. 
Antibodies against Cone Arrestin and RBPMS were also used in whole mount            
preparations, at 10x the concentrations used for sections.  
Secondary antibodies were: donkey anti-mouse Alexa Fluor 488 (715-547-003) and          
donkey anti-rabbit Rhodamine Red X (711-295-152) from Jackson ImmunoResearch         
Laboratories, Inc., USA; these were diluted 1:800 both for retinal sections and whole             
mount preparations.  
After multiple washing steps in PBS, specimens were mounted in Vectashield Antifade            
Mounting Medium (H-1000; Vector Laboratories, Burlingame, CA), coverslipped and         
sealed with nail polish. 
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Imaging and data analysis 
Retinal whole mounts were imaged with a Zeiss Axioplan light microscope equipped            
with a Zeiss Axiocam color camera using a Plan Neofluar 1,25x/0,035 objective to             
measure retinal surface prior and post confocal microscopy. Image acquisition for           
morphometric observations in whole-mounts and vertical sections was performed with a           
Leica TCS-SL confocal microscope equipped with 488 and 453 lasers, using a Plan             
Apochromat 40x/1.40 oil objective, employing identical laser and acquisition settings for           
all samples. For cell counts in retinal whole-mounts, four fields (250 x 250 micrometers)              
were acquired at each eccentricity of the retina, altogether representing 1/15 of the total              
area of the tissue. Images were saved as TIFF files and transferred to a MetaMorph               
image analyzer, where semi-automatic cell counts were performed. The total number of            
cells/retina were calculated. 
dLGN and V1 morphological analysis 
Tissue preparation and histology 
Male mice (2-3 months old) were euthanized with isoflurane (2% in pure oxygen) and              
sacrificed by cervical dislocation. Brains were quickly removed and cut along the            
midline. Right hemispheres were processed for immunohistochemistry, while left         
hemispheres were Golgi stained as described below. All steps of sectioning, imaging,            
and data analysis were conducted blindly to genotype.  
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For PSD95 and VGAT IHC, right hemispheres were fixed by immersion in 4%             
paraformaldehyde (PFA) in 0.1 M PB pH 7.4, stored in fixative for 48 h, kept in 20%                 
sucrose w/w dissolved in 0.1 PB. for an additional 24 h and then frozen with cold ice.                 
Right hemispheres were cut with a freezing microtome into 30-µm-thick coronal sections            
that were serially collected. One out of 4 free-floating sections from the lateral             
geniculate nucleus (LGN) and from the visual cortex (V1) were incubated for 24 h at 4°C                
with the following primary antibodies: a rabbit polyclonal anti-PSD95 antibody (1:1000;           
Abcam Ltd. Cambridge UK, ab 18258), or or rabbit polyclonal anti-VGAT antibody            
(1:600; Synaptic System, Göttingen, Germany). Sections were then incubated at room           
temperature for 2 h with a CY3-conjugated goat anti-rabbit IgG (1:200; Jackson Immuno             
Research Laboratories, Inc. PA, USA).  
For Golgi staining, left hemispheres were Golgi stained using the FD Rapid Golgi Stain              
TM Kit (FD NeuroTechnologies, MD USA). Briefly, hemispheres were immersed in the            
impregnation solution containing mercuric chloride, potassium dichromate, and        
potassium chromate, and stored at room temperature in darkness for 2-3 weeks.            
Hemispheres were cut with a microtome in 100-µm-thick coronal sections that were            
directly mounted on gelatin-coated slides and were air dried at room temperature in the              
dark for an additional 2-3 days. After drying, sections were rinsed with distilled water              
and subsequently stained in the developing solution of the kit.  
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Imaging and data analysis 
All analyses were carried out in cortical layers 2/3 and 5 from the primary visual cortex                
(V1) and in the lateral geniculate nucleus (LGN) identified according to the Paxinos             
mouse brain atlas ​(Paxinos 2007)​. For quantification of PSD95 and VGAT           
immunoreactive puncta, images were acquired using a LEICA TCS SL confocal           
microscope (Leica Microsystems; 63X oil immersion objective, NA 1.32; zoom factor =            
8). Three to four sections per animal were analyzed and puncta counts were performed              
on a single plan, 1024 X 1024 pixel images. Counting was carried out using Image Pro                
Plus software (Media Cybernetics, Silver Spring, MD USA) and the number of PSD95             
and VGAT immunoreactive puncta was expressed per µm2. For the quantification of            
dendritic spines, images were acquired using a Leica light microscope (Leica           
Microsystems; 100X oil immersion objective, NA 1.4). Dendritic spine density was           
measured by manually counting the number of dendritic spines on dendritic segments in             
the LGN and on secondary dendrites of pyramidal neurons of layer 2/3 and layer 5 of                
the V1. In each mice, 15 dendritic segments (segment length: 10-30 µm) from each              
zone were analyzed and the linear spine density was calculated by dividing the total              
number of counted spines by the length of the sampled dendritic segment. Based on              
their morphology, dendritic spines can be divided into five different classes (immature            
spines: filopodium-like, thin- and stubby-shaped; mature spines: mushroom- and         
cup-shaped), which also reflect their state of maturation. The total number of spines             
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was expressed per µm and the number of spines belonging to each class was counted               
and expressed as a percentage.  
Intrinsic Optical Signal Imaging 
Surgery 
Surgery for IOS imaging was performed as described in ​(Mazziotti et al. 2017)​. Mice              
were anesthetized isoflurane (3% induction; 1% maintenance) and head fixed on a            
stereotaxic frame using ear bars. Body temperature was controlled using a heating pad             
and a rectal probe to maintain the animals’ body at 37ºC. Local anesthesia was              
provided using subcutaneous lidocaine (2%) injection and the eyes were protected with            
a dexamethasone-based ointment (Tobradex, Alcon Novartis). The scalp was         
thoroughly cleaned with 70% ethanol, then it was removed and the skull was carefully              
cleaned with saline. The skin was secured to the skull using cyanoacrylate. A thin layer               
of cyanoacrylate was poured over the exposed skull to attach a custom-made metal ring              
(9 mm internal diameter) centered over the binocular visual cortex. When the glue dried              
off, a drop of transparent nail polish was spread over the area to ameliorate optical               
access. After surgery, the animals were allowed to recover fully in a heated box and               
monitored to ensure the absence of any sign of discomfort. Before any other             
experimental procedure, mice were left to recover for 24/48 hours. During this period,             
paracetamol (5 mg/ml) was administered in the water as antalgic therapy. 
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Imaging and data analysis 
IOS recordings were performed under isoflurane anesthesia (3%). Images were          
visualized using a custom Leica microscope (Leica Microsystems). Red light illumination           
was provided by 8 individually addressable LEDs (WS2812) attached to the objective            
(Leica Z6 APO coupled with a Leica PlanApo 2.0X 10447178) by a custom 3D printed               
conical holder. Visual stimuli were generated using Matlab Psychtoolbox and presented           
on a gamma corrected 24” monitor (C24F390FHU). 
Horizontal sine wave gratings were presented in the binocular portion of the visual field              
enclosed in a gaussian envelope spanning -10 to +10 degrees of azimuth and -5 to +60                
(full monitor height) degrees of altitude, with a spatial frequency of 0.03 cycles per              
degree, mean luminance 20 cd/m2 and a contrast of 90%. The stimulus consisted in the               
abrupt contrast reversal of a grating with a temporal frequency of 4 Hz for 1 second,                
time locked with a 12-bit depth acquisition camera (PCO edge 5.5) using a parallel port               
trigger. Interstimulus time was 13 seconds. Frames were acquired at 30 fps with a              
resolution of 540 x 640 pixels. The signal was averaged for at least 4 groups of 20 trials                  
and downsampled in time to 10 fps and in space to 270 x 320 pixels. Fluctuations of                 
reflectance (R) for each pixel were computed as the normalized difference from the             
average baseline (ΔR/R). For each recording, an image representing the mean evoked            
response was computed by averaging frames between 0.5 to 2.5 seconds after            
stimulation. The mean image was then low-pass filtered with a 2D average square             
spatial filter (7 pixels). To select the binocular portion of the primary visual cortex for               
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further analysis, a region of interest (ROI) was automatically calculated on the mean             
image of the response by selecting the pixels in the lowest 20% ΔR/R of the range                
between the maximal and minimal intensity pixel ​(Cang et al. 2005)​. To weaken             
background fluctuations a manually selected polygonal region of reference (ROR) was           
subtracted. The ROR was placed where no clear response, blood vessel artifact or             
irregularities of the skull were observed ​(Heimel et al. 2007) Mean evoked responses             
were quantitatively estimated as the average intensity inside the ROI. 
Statistical analysis 
Statistical analysis was carried out in Graphpad Prism 7. For each result, the statistical              
tests used are specified in the figure legends and in the respective result section.              
Briefly, when two different normally distributed experimental groups were compared, we           
used a two-tail Student’s t-test; When the proportion of observations in mutually            
exclusive classes were compared we used chi-square test. When more than two            
normally distributed groups were compared we used a one-way ANOVA test.  
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Legends to Figures 
Figure 1 
CDKL5 null mice show normal retinal morphology. ​A: Western Blot analysis on adult             
male CDKL5​-/y and WT (CDKL5​+/y​) retinal homogenates showing CDKL5 expression.          
B,C: Retinal sections stained for cone photoreceptors (Cone Arrestin, red) and rod            
outer segments (Rhodopsin, green). The overall structural organization of photoreceptor          
cells is identical in the two experimental groups. ​D,E: Representative images from            
retinal whole mount preparations of CDKL5​+/y (D) and CDKL5​-/y (E) stained for            
cone-Arrestin as a cone marker. ​F: Quantitation of the total number of cones showed no               
statistical significance between the two groups (two-tailed Student's t-test p=0.435).          
G,H: Representative images from retinal whole mount preparations of CDKL5​+/y (G) and            
CDKL5​-/y (H) stained for RNA-binding protein with multiple splicing (RBPMS) as a retinal             
ganglion cells marker. ​I: Quantitation of the total number of cones (I) showed no              
statistical significance between the two groups (two-tailed Student's t-test p=0.098).          
Scale bars = 20 μm. Error bars represent SEM. 
Figure 2 
Morphological synaptic abnormalities in CDKL5 KO dLGN. ​A: Representative image of           
a Golgi stained coronal section containing the dLGN and showing the cortical layering             
that has been used in sections containing V1. ​B: Quantitation of spine density in Golgi               
stained dLGN slices showing a reduction in CDKL5​-/y mice. (two-tailed Student's t-test            
p=0.0259) ​C: Quantitation of the relative proportion of mature and immature spines in             
Golgi stained dLGN slices showing an increased fraction of immature spines in CDKL5​-/y             
mice. (χ​2 ​test p=0.0027) ​D: Quantitation of spine morphology in Golgi stained dLGN             
slices showing a pattern of decreased morphological maturity in CDKL5​-/y mice. (χ​2 ​test             
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p=0.0009). ​E: Representative images of PSD95 punctate staining from CDKL5​-/y and           
CDKL5​+/y dLGN. ​F: Quantitation of PSD95​+ puncta density showing a reduction in            
CDKL5​-/y mice. (two-tailed Student's t-test p<0.0001). ​G: Representative images of          
VGAT punctate staining from CDKL5​-/y and CDKL5​+/y dLGN. ​H: Quantitation of VGAT​+            
puncta density showing no difference in CDKL5​-/y mice. (two-tailed Student's t-test           
p=0.706). (* p<0.05; ** p<0.01; *** p<0.001). Scale bars: (A, insets) = 1μm, (E,G) =               
2μm. Error bars represent SEM. 
Figure 3 
Morphological synaptic abnormalities in CDKL5 KO V1. ​A: Quantitation of spine density            
in Golgi stained V1 slices showing a reduction in CDKL5​-/y mice. (two-tailed Student's             
t-test P=0.026). In the insets are shown representative images of dendritic spines after             
Golgi staining from CDKL5​-/y and CDKL5​+/y V1 neurons. ​B: Quantitation of the relative             
proportion of mature and immature spines in Golgi stained V1 slices showing an             
increased fraction of immature spines in CDKL5​-/y mice. (Fisher’s exact test p<0.001) ​C:             
Quantitation of spine morphology in Golgi stained V1 slices showing a pattern of             
decreased morphological maturity in CDKL5​-/y mice. (χ​2 ​test p<0.001). ​D:          
Representative images of PSD95 punctate staining from CDKL5​-/y and CDKL5​+/y V1. ​E:            
Quantitation of PSD95​+ puncta density showing a reduction in CDKL5​-/y mice. (two-tailed            
Student's t-test p<0.001). ​F: Representative images of VGAT punctate staining from           
CDKL5​-/y and CDKL5​+/y dLGN. ​G: Quantitation of VGAT​+ puncta density showing an            
increase in CDKL5​-/y mice. (two-tailed Student's t-test p=0.0135). (* p<0.05; ** p<0.01;            
*** p<0.001). Scale bars: (D,F) = 2μm. Error bars represent SEM. 
Figure 4 
Synaptic morphology in the dLGN and V1 of cKO mice with deletion of CDKL5 in               
cortical excitatory neurons. ​A: Quantitation of spine density in Golgi stained dLGN slices             
from cKO (CDKL5​flox/y​;emx1-CRE​+/-​) and CDKL5​+/y mice showing no significant         
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difference between the two groups. (two-tailed Student's t-test p=0.528) ​B: Quantitation           
of the relative proportion of mature and immature spines in Golgi stained dLGN slices              
showing no difference in the fraction of mature and immature spines in cKO mice              
compared to WT controls. (χ​2 ​test p=0.0612) ​C: Quantitation of spine morphology in             
Golgi stained dLGN slices showing no difference in morphological maturity in cKO mice.             
(χ​2 ​test p=0.163). ​D: Representative images of PSD95 punctate staining from cKO and             
CDKL5​+/y dLGN. ​E: Representative images of VGAT punctate staining from cKO and            
CDKL5​+/y dLGN. ​F: Quantitation of PSD95​+ puncta density showing no difference.           
(two-tailed Student's t-test P=0.533). ​G: Quantitation of VGAT​+ puncta density showing           
no difference. (two-tailed Student's t-test P=0.812). (* p<0.05; ** p<0.01; *** p<0.001).            
Calibration bar =  2μm. Error bars represent SEM. 
Figure 5 
Cortical visual responses are impaired in cKO mice with deletion of CDKL5 in cortical              
excitatory neurons. ​A: Quantitation of the average amplitude of the intrinsic signal            
between the experimental groups, cKO, floxed controls (CDKL5​flox/y​) and emx1-CRE          
driver controls (emx1-CRE​+/-​), showing a significant reduction of the evoked visual           
responses in cKO mice with respect to both control groups. (one way ANOVA p=0.004;              
post-hoc Holm-Sidak’s multiple comparisons test, emx1-CRE​+/- ​vs cKO, p=0.0342;         
CDKL5​flox/y ​vs cKO, p=0.0043) ​B: Quantitation of the average amplitude of the intrinsic             
signal in CDKL5 null animals showing a significant reduction with respect to controls.             
(two-tailed Student's t-test P<0.001) ​C: Average time course of the intrinsic signal in the              
primary visual cortex after visual stimulation for the experimental groups in A. Each area              
represents mean ± SEM for all the mice in the group. ​D: Representative images of a                
typical intrinsic signal response to visual stimulation localized in the primary visual            
cortex. Dark areas represent active portions of brain tissue. (* p<0.05; ** p<0.01; ***              
p<0.001). Scale bar(C) = 1.8 mm. Error bars represent SEM. 
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Figure 6 
A​: Quantitation of spine density in Golgi stained V1 slices from cKO            
(CDKL5flox/y;emx1-CRE+/-) and CDKL5+/y mice showing an increase in cKO mice.          
(two-tailed Student's t-test p=0.0014) ​B​: Quantitation of the relative proportion of mature            
and immature spines in Golgi stained V1 slices showing an increased fraction of             
immature spines in cKO mice compared to WT controls. (χ2 test p<0.001) ​C​:             
Quantitation of spine morphology in Golgi stained V1 slices showing a pattern of             
decreased morphological maturity in cKO mice. (χ2 test p<0.001). ​D​: Representative           
images of PSD95 punctate staining from cKO and CDKL5+/y V1. ​E​: Representative            
images of VGAT punctate staining from cKO and CDKL5+/y V1. ​F​: Quantitation of             
PSD95+ puncta density showing an increase in cKO mice. (two-tailed Student's t-test            
P=0.0085). ​G​: Quantitation of VGAT+ puncta density showing an increase in cKO mice.             
(two-tailed Student's t-test P<0.001). (* p<0.05; ** p<0.01; *** p<0.001). Calibration bar            
= 2μm. Error bars represent SEM. 
Abbreviations 
CVI: Cortical Visual Impairment 
IOS: Intrinsic Optical Signal 
dLGN: dorsal Lateral Geniculate Nucleus 
V1: Primary visual cortex 
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